2025 SPS Seattle | Taletrectinib Pushing Boundaries in ROS1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
0% Complete
Course Content
Credits
- AMA PRA Category 1 Credit™Non-CME
Course Details
- Duration
- 0.00 hour
- Released
- Oct 5, 2025
- Last Review
- Oct 5, 2025
- Expires
- Oct 5, 2026
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Accreditation
NA
